DIALYSIS · CCN 052635

DaVita Bakersfield Brimhall Dialysis

Bakersfield, CA 93312

DialysisProfitDaVita
$6.0M
TOTAL REVENUE
18.1%
OPERATING MARGIN
3 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$6.0M
Total costs
$4.9M
Operating income (rev − costs)
$1.1M
Operating margin
18.1%
Total charges
$6.1M
Total treatments
14,687
Dialysis stations
20

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.8156—
Fistula Rate
DFC_FISTULA_RATE
75.2107—
Five Star Rating
DFC_FIVE_STAR
3——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
0.7725—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
141.373—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.47——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
11107—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
29.7298—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
20.397—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
18.266—
Standardized ED Visits Ratio
DFC_SEDR
0.8737—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
50.328—